Literature DB >> 30293657

Chronic Kidney Disease as a Possible Predictor of Left Atrial Thrombogenic Milieu Among Patients with Nonvalvular Atrial Fibrillation.

Shun Kizawa1, Takahide Ito2, Kanako Akamatsu1, Noboru Ichihara1, Shimpei Nogi1, Masatoshi Miyamura1, Yumiko Kanzaki1, Koichi Sohmiya1, Masaaki Hoshiga1.   

Abstract

Patients with chronic kidney disease (CKD) experiencing atrial arrhythmia are hypothesized to have elevated CHADS2 and CHA2DS2-VASc scores, thereby predisposed to left atrial (LA) thrombus formation and subsequent thromboembolism. We examined possible association of LA thrombogenic milieu (TM) with CKD in patients with nonvalvular atrial fibrillation. A total of 581 patients (181 women; mean age, 67 years) who underwent transesophageal echocardiography were examined. Patients were divided into 4 groups based on the estimated glomerular filtration rate (eGFR) (ml/min/1.73 m2): eGFR ≥90 (n = 29), 60≤ eGFR <90 (n = 329), 30≤ eGFR <60 (n = 209), and eGFR <30 (n = 14). TM was defined as the presence of LA thrombus, dense spontaneous echo contrast, or LA appendage velocity ≤25 cm/s. Of 581 patients, 147 (25%) had TM. The prevalence of TM increased with decreasing eGFR (4%, 18%, 36%, and 86% for each group, p <0.001). Similar trends were observed for some of the clinical and echocardiographic variables including CHA2DS2-VASc score and LA size. Multivariate logistic regression analysis revealed that every 10 ml/min/1.73 m2 decrement in eGFR was a significant independent correlate of TM (odds ratio 0.80, p = 0.005), along with nonparoxysmal atrial fibrillation (AF) (odds ratio 0.45, p = 0.004), higher CHA2DS2-VASc score (odds ratio 1.24, p = 0.012), every 5 ml/m2 increment in LA volume index (odds ratio 1.57, p <0.001), and every 10% decrement in left ventricular ejection fraction (odds ratio 0.51, p <0.001). In conclusion, CKD may be a significant risk factor for LA thrombus formation in patients with nonvalvular atrial fibrillation.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2018        PMID: 30293657     DOI: 10.1016/j.amjcard.2018.08.058

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Analysis of risk factors for thrombosis of the left atrium/left atrial appendage in patients with non-valvular atrial fibrillation.

Authors:  He Du; Ke Bi; Lisha Xu; Feng Chen; Wenfeng Xiong; Yin Wang
Journal:  Cardiovasc J Afr       Date:  2021-04-16       Impact factor: 1.167

2.  Retrospective Study of 1255 Non-Anticoagulated Patients with Nonvalvular Atrial Fibrillation to Determine the Risk of Ischemic Stroke Associated with Left Atrial Spontaneous Echo Contrast on Transesophageal Echocardiography.

Authors:  Kesen Liu; Yukun Li; Kui Wu; Junlei Li; Yong Zhu; Fei Guo; Rong Bai; Jianzeng Dong
Journal:  Med Sci Monit       Date:  2021-12-11

Review 3.  Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies.

Authors:  Wern Yew Ding; Stephanie Harrison; Dhiraj Gupta; Gregory Y H Lip; Deirdre A Lane
Journal:  Front Med (Lausanne)       Date:  2020-02-21

4.  CHA2DS2-VASc Score as a Predictor for Left Atrial Thrombus or Spontaneous Echo Contrast in Patients with Nonvalvular Atrial Fibrillation: A Meta-Analysis.

Authors:  Ping Sun; Zhi Hao Guo; Hong Bin Zhang
Journal:  Biomed Res Int       Date:  2020-07-11       Impact factor: 3.411

5.  Risk of left atrial appendage thrombus in patients with atrial fibrillation and chronic kidney disease.

Authors:  Monika Budnik; Monika Gawałko; Iwona Gorczyca; Beata Uziębło-Życzkowska; Paweł Krzesiński; Janusz Kochanowski; Piotr Scisło; Anna Michalska; Olga Jelonek; Katarzyna Starzyk; Agnieszka Jurek; Marek Kiliszek; Beata Wożakowska-Kapłon; Grzegorz Gielerak; Krzysztof J Filipiak; Grzegorz Opolski; Agnieszka Kapłon-Cieślicka
Journal:  Cardiol J       Date:  2020-03-24       Impact factor: 2.737

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.